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The ability of pancreatic b-cells to respond to increased demands for insulin during metabolic stress critically
depends on proper ribosome homeostasis and function. Excessive and long-lasting stimulation of insulin
secretion can elicit endoplasmic reticulum (ER) stress, unfolded protein response, and b-cell apoptosis.
Herewe show that the diabetes susceptibility gene JAZF1 is a key transcriptional regulator of ribosomebiogen-
esis, global protein, and insulin translation. JAZF1 is excluded from the nucleus, and its expression levels are
reduced uponmetabolic stress and in diabetes.Genetic deletion of Jazf1 results in global impairment of protein
synthesis that is mediated by defects in ribosomal protein synthesis, ribosomal RNA processing, and amino-
acyl-synthetase expression, thereby inducing ER stress and increasing b-cell susceptibility to apoptosis.
Importantly, JAZF1 function and its pleiotropic actions are impaired in islets of murine T2D and in human islets
exposed to metabolic stress. Our study identifies JAZF1 as a central mediator of metabolic stress in b-cells.
INTRODUCTION
Glucose-induced insulin secretion (GSIS) from pancreatic
b-cells plays a key role in glucose homeostasis. Functional
and sufficient b-cells are required to maintain normoglycemia.
Genetic and environmental factors as well as aging are major
risk factors for the gradual decline in insulin secretion.
Genome-wide association studies (GWASs) have revealed a
variety of type 2 diabetes (T2D) susceptibility genes, many of
which appear to primarily be involved in b-cell differentiation
and function (Bonnefond et al., 2010). Three defects have
consistently been reported in patients with T2D: gradual
decline in b-cell function and dedifferentiation and a reduction
in b-cell mass (Accili et al., 2016). The molecular mechanisms
of b-cell failure in T2D are incompletely understood, but several
lines of evidence suggest that mitochondrial dysfunction
(Mulder, 2017), oxidative and endoplasmic reticulum (ER)
stress (Keane et al., 2015), dysfunctional fatty acid metabolism
(Prentki et al., 2013), glucolipotoxicity (Poitout and Robertson,
2008), and amyloid deposition (Hull et al., 2004) contribute to
functional b-cell alterations and loss of b-cell mass by
apoptosis and compromised proliferation. The functional adap-
tation of b-cells and the response to chronic metabolic stress
have been linked to ER stress and the unfolded protein
response (UPR) (Back and Kaufman, 2012).
Proinsulin biosynthesis is regulated by nutrients, most notably
glucose. Short-term glucose stimulation (%2h) leads to a rapid
(2-fold) increase in total protein synthesis and an 20-fold in-
crease in proinsulin synthesis (Itoh and Okamoto, 1980). This pro-
cess is mediated almost entirely by enhanced translation of pre-
existing mRNAs that are translocated from an inert cytosolic
pool to translationally active membrane-bound polysomes on
the rough ER, and ultimately through an augmented rate of initia-
tion, facilitated through increased availability of the translational
ternary complex and brought about by the dephosphorylation of
eIF2a (Scheuner et al., 2005; Sonenberg and Hinnebusch,
2009). Prolonged glucose stimulation also leads to increases in
preproinsulin mRNA levels (2-fold), increased insulin mRNA sta-
bility, and a corresponding increase in proinsulin translation (R10-
fold) (Brunstedt and Chan, 1982). However, chronic overproduc-
tion of insulin per se (i.e., in insulin resistance) or geneticmutations
(e.g., in the insulin gene) can lead to the formation of misfolded
proteins that may generate ER stress (Arunagiri et al., 2018).
This in turn can trigger intracellular signaling events that ultimately
activate transcription of ER chaperones, oxidoreductases, and
ER-associated protein degradation (ERAD) components.
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Figure 1. Jazf1 Levels and Localization of b-Cells in Normoglycemia and in T2D
(A) Association analyses of indicated phenotypes and quantitative traits in European-ancestry participants of UK Biobank. p values of associations are indicated,
while odds ratio or estimates are color-coded. p values < 5e-8 are significant. Number of participants analyzed per trait ranged between 354,259 and 487,867.
(B–D) Expression levels of Jazf1 in islets from healthy humans and T2D patients (n = 5) (B), islets from Leprdb/db and control littermate mice at 6 and 28 weeks (n =
3) (C), and mouse islets cultured in 3 mM (LG) and 24 mM (HG) glucose for 24 h (n = 3) (D).
(legend continued on next page)




Normally, this response enhances the cell’s capacity to sustain
protein secretion during times of high demands. If adaptive UPR
outputs are effective, this will lead to a reduction of unfolded pro-
teins and restoration of homeostasis. However, if ER stress per-
sists, the UPR switches its physiological output from promoting
adaptation to instead promoting self-destruction, usually through
apoptosis (Papa, 2012). The regulation of b-cell gene expression
in response to metabolic stress has been extensively studied at
the transcriptional level, but regulation of mRNA translation,
including ribosome biogenesis and rRNA processing, has
received less attention. Likewise, how these processes are regu-
lated transcriptionally and how they may be linked to ER stress
and the UPR pathways during the development of T2D is not
understood.
Juxtaposed with another zinc finger (ZnF) protein 1, JAZF1
(TIP27, ZNF802) encodes a 27 kDa protein with three C2H2-
type ZnFs and functions as a repressor of DNA response
element 1 (DR1)-dependent transcription of nuclear receptor
subfamily 2, group C, member 2 (NR2C2, TR4) (Nakajima
et al., 2004). JAZF1 represses NR2C2 transcriptional activity
via direct binding to the ligand-binding domain (LBD) of NR2C2
(Omori et al., 2005; Lee et al., 1997; Tanabe et al., 2007).
GWASs have identified gene variants in that are linked to insu-
lin secretion and increased susceptibility to develop T2D (Grarup
et al., 2008; Zeggini et al., 2008). JAZF1 levels are decreased in
pancreatic islet of T2D patients, and increased transcript levels
are associated with higher insulin secretion (Taneera et al.,
2012). Gene variants involving JAZF1 are also associated with
height (Manolio, 2010), risk for prostate cancer (Thomas et al.,
2008), and endometrial stromal tumors (Koontz et al., 2001).
Although NR2C2 may have functions in energy homeostasis
and inflammation (Liu et al., 2007; Kang et al., 2011; Yang
et al., 2014; Meng et al., 2018), no studies have explored its
role in pancreatic b-cells, except a recent study demonstrating
allele-specific transcriptional activity at T2D-associated single-
nucleotide polymorphisms in regions of open chromatin at the
JAZF1 locus (Fogarty et al., 2013).
In this study we used genetic, molecular, biochemical, and
physiological approaches to investigate the role of JAZF1 in islet
gene regulation and report a previously unrecognized role as an
essential regulator of mRNA translation through coordinating
protein gene expression, ribosome biogenesis, and rRNA pro-
cessing. We further show that impaired JAZF1 function in T2D
contributes to ribosomal and ER stress, activation of apoptosis
pathways, and ultimately b-cell demise.
RESULTS
Genetic JAZF1 Variance, Decreased JAZF1 Expression,
and Nuclear JAZF1 Localization in Pancreatic b-Cells
Are Associated with T2D and Metabolic Stress
We studied an intronic variant in the JAZF1 gene (rs1635852;
pairwise R2 < 0.01, minor allele frequency in dataset 49.63%),
that has been shown to display allelic differences in enhancer ac-
tivity with the T2D risk allele T showing lower transcriptional ac-
tivity (Fogarty et al., 2013). Genotypes from400,000 European-
ancestry participants fromUKBiobank, a U.K. population-based
cohort of people 40–69 years of age (Bycroft et al., 2018), were
analyzed to confirm that variations in the JAZF1 genomic locus
predispose to T2D, as shown by significant associations of the
rs1635852_TT genotype with diabetes phenotypes and traits.
Interestingly, the association of the risk genotype with lower
body mass index indicates that JAZF1 may have a key role in
b-cell function rather than in organs regulating insulin sensitivity
and energy homeostasis (Figure 1A).
We first examined the expression of Jazf1 across metabolic
tissues in mice fed with a chow diet. We found that Jazf1 tran-
script levels were most abundant in pancreatic islets, followed
by adipose tissue, where expression was previously reported
to be highest in all tissues (Figure S1A) (Ho et al., 2013; Yang
et al., 2015).
Several studies have shown that Jazf1 mRNA is decreased in
T2D islets and that increased transcript levels are associated
with higher insulin secretion (Taneera et al., 2012). Indeed, we
found reduced JAZF1 expression in human islets from T2D or-
gan donors compared with healthy donors (Figure 1B). Further-
more, in Leprdb/db compared with control Lepr+/? mice, Jazf1
transcript levels were slightly decreased at 6 weeks of age and
reduced by more than 2-fold at 28 weeks of age, at which time
Leprdb/db mice became profoundly diabetic (Figure 1C). Pancre-
atic mouse islets from wild-type (WT) mice cultured in high-
glucose conditions also had decreased Jazf1 levels (Figure 1D).
Last, we found that Jazf1 expression was decreased in islets of
patients with type 1 diabetes (T1D) and in a mouse model of T1D
(NOD) (Figures S1B–S1D).
Jazf1 has a putative nuclear localization sequence (NLS),
located within the second ZnF motif (Figure S1E). We noticed a
significant homology of the C-terminal ZnF motif between
JAZF1 and yeast Sfp1 (Figure S1F), a transcription factor that
controls the expression of more than 60 genes involved in ribo-
some biogenesis, cell cycle G2/M transition, and DNA damage
response (Fingerman et al., 2003; Albert et al., 2019). Immunoflu-
orescence staining revealed nuclear localization in transformed
rat and human b-cell lines exposed to low and high glucose, indi-
cating a role in proliferation (Figures S1G and S1H), a notion that
was supported by reduced cell division when Jazf1 was silenced
(Figure S1I). In primary b-cells, JAZF1 was localizedmostly in the
cytosol at low glucose but translocated to the nucleus at high
glucose levels (Figure 1E). Similarly, we observed a predominant
cytosolic distribution of JAZF1 in WT mice fed ad libitum a chow
diet. In contrast, JAZF1was locatedmainly in the nuclei of b-cells
from hyperglycemic Akita and Leprdb/db mice, in which T2D de-
velops as a result of ER stress due to a mutation in Ins2 and se-
vere insulin resistance, respectively (Figure 1F). This finding was
confirmed by subcellular fractionation and immunoblotting ex-
periments in islets of Leprdb/db and control mice (Figure S1J).
(E–G) Immunohistochemistry of isolated mouse b-cells cultured in low (3 mM) and high (15 mM) glucose for 1 h (E), pancreatic sections of wild-type (WT), Akita,
and Leprdb/dbmice (24 weeks of age) (F), and pancreatic biopsies of six healthy and six T2D human subjects (G), stained for JAZF1, Insulin, and DNA (DAPI). Scale
bars: 25 mm (E) and 100 mm (E–G). Numbers in (E) and (G) represent anonymized identifiers. Clinical data of human subjects (G) is shown in Figure S1K.
Data are presented as mean ± SD. *p% 0.05, **p% 0.01, and ***p% 0.001 by Student’s t test.
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We also found that JAZF1 was preferentially localized in the
nuclei of b-cells in pancreatic tissue sections of human T2D sub-
jects, whereas it localized mainly to the cytosol of non-diabetic
controls (Figures 1G and S1K). Last, in contrast to JAZF1,
NR2C2 was always associated with the nucleus, irrespective of
the glucose levels, in primary b-cells or in Akita mice (Figures
S1L and S1M). These results demonstrate that JAZF1 expres-
sion levels and cellular compartmentalization are regulated by
metabolic stress conditions, leading to a nuclear localization in
response to elevated glucose concentrations.
Increased Susceptibility of JAZF1-Depleted b-Cells to
ER Stress-Induced Apoptosis
To study the function of JAZF1, we generated b-cell-specific
Jazf1 knockout mice by crossing Jazf1fl/fl mice with RIP-Cre
transgenicmice that express Cre-recombinase under the control
of the rat insulin 2 promoter (called bJazf1KO). PCR and western
blot analysis confirmed the specific ablation of Jazf1 in islets but
not in other metabolic tissues (Figures S2A–S2C). bJazf1KO
mice were indistinguishable from control Jazf1fl/fl littermates
(called bWt) with regard to weight, blood glucose, and GSIS in
isolated islets (Figures S2D–S2F). Pancreatic insulin content
and b-cell masswere reduced in bJazf1KOmice at age 16weeks
compared with bWt mice, with a similar percentage of Ki-67-
positive b-cells (Figures S2G–S2I). Challenging animals with a
high-fat diet (HFD) for 12 weeks resulted in a similar phenotype
with regard toweight, blood glucose, and glucose tolerance (Fig-
ures S2J–S2L). Similar to chow-fed mice, bJazf1KO animals on
theHFD had reduced b-cell mass and displayed lower b-cell pro-
liferation compared with bWt mice (Figures S2M and S2N).
We next studied the consequences of genetic Jazf1 ablation in
Akitamice, a well-characterized genetic T2Dmodel, due to unre-
solved ER stress and b-cell apoptosis (Yoshioka et al., 1997;
Wang et al., 1999). Akita bJazf1KO mice exhibited similar body
weight but higher blood glucose levels compared with Akita
bWt mice (Figures 2A and 2B). The b-cell mass was reduced
by 50% in Akita bJazf1KO mice (Figure 2C), and measurements
of b-cell proliferation by in vivo BrdU assays showed a 70%
reduction compared with Akita bWt mice (Figure 2D). Further-
more, plasma insulin levels were decreased and proinsulin levels
increased in Akita bJazf1KO animals (Figures 2E and 2F), with no
changes in the levels of insulin-processing genes (Pcsk1, Pcsk2,
Cpe) (Figure S2O).
Unresolved ER stress can lead to b-cell death through the acti-
vation of p53-dependent apoptotic pathways in murine (Hoshino
et al., 2014) and human (Tornovsky-Babeay et al., 2014) T2D.We
performed TUNEL staining and cleaved caspase-3 assays and
found that b-cell apoptosis was increased in 8-week-old Akita
bJazf1KO mice compared with Akita control animals (Figures
2G and 2H). A similar response was observed when challenging
islets of Akita bJazf1KO with high glucose for 24 h, followed by
thapsigargin (TG) treatment for 5 h (Figure 2H). Interestingly,
knockdown of Jazf1 in INS1E cells was sufficient to activate
ER stress genes PERK and elF2a (Figure 2I) as well as the p53
pathway, as measured by increased phosphorylation of
p53(Ser15), p53 accumulation, and activation of its targets P21
and MDM2, in unstressed conditions (Figure 2J).
We next studied the response of Jazf-depleted INS1E and
MIN6 cells to various stresses: treatment of cells with a cytokine
cocktail (CC) or TG, which are known to induce ER dysfunction
and initiate cell death (Cardozo et al., 2005; Lerner et al.,
2012), led to increased Ser51 phosphorylation of eIF2a and
more apoptosis as shown by higher levels of cleaved caspase-
3 compared with si-Ctrl-transfected cells (Figures 2K–2M). Of
note, the expression of JAZF1 protein levels decreased in human
primary islets exposed to a diabetogenic milieu (high glucose,
palmitic acid, and cytokines) (Figure 2N). Furthermore, JAZF1
levels also decreased in islets exposed to ER stress (Figure 2H)
and to INS1E cells treated with TG (Figure S2P). These results
are also consistent with increased ER stress markers in islets
from Leprdb/db mice that are known to undergo ER stress-
induced apoptosis (Figures 2O and S2Q). Interestingly, silencing
Nr2c2 in b-cells conferred protection to ER stress (Figures S2R
and S2S). Of note, Nr2c2 levels were unaffected in b-cells with
induced ER stress (Figure S2T). Taken together, these data pro-
vide a link between JAZF1/NR2C2 complex and ER stress in
pancreatic b-cells.
When protein production exceeds the ER processing capacity
or mutant proteins such as Ins2Akita C96Y are not properly
folded, they can activate a signaling network called the UPR.
The transcriptome analysis of islets from bJazf1KO and bWt
mice identified increased levels of several UPR genes that
Figure 2. Loss of JAZF1 Function in b-Cells Exacerbates ER Stress and Apoptosis In Vivo and In Vitro
(A–G) Body weight (A), blood glucose levels (B), pancreatic b-cell mass (C), TUNEL staining of insulin-positive islet cells (D), percentage of BrdU-positive b-cells
(E), plasma insulin levels (F), and proinsulin levels (G) in mice with indicated genotypes. Islet measurements (C–G) were carried out in 8-week-old mice. In (A), (B),
(F), and (G), n = 6 for each group; in (D) and (E)( n = 3). Scale bar: 25 mm.
(H) Immunoblot analysis of cleaved caspase in isolated islets from Akita bJazf1KO and Akita bWt littermates of 8-week-old animals (top) and after culturing in
24 mM glucose (HG) and TG for 5 h (bottom). Anti-tubulin antibodies were used as a loading control (n = 3). Scale bar: 25 mm.
(I and J) Immunoblot analysis of indicated (phospho) proteins from INS1E cells transfected with siRNAs targeting Jazf1 (si-Jazf1) or control (si-Ctrl) to measure ER
stress (I) and p53 pathway activation and apoptosis (J).
(K–M) Immunoblot analysis of cleaved caspase-3 from INS1E (K) and MIN6 (L and M) cells transfected with siRNAs targeting Jazf1 and exposed to a cytokine
cocktail (CC; IL-1b, IFN-g, and TNF-a) for 24 h (K and L) or thapsigargin (M) for 5 h.
(N) Immunoblot analysis of indicated proteins from human pancreatic islets that were exposed to high glucose (Glc), palmitic acid (Pa), and a cytokine cocktail
(CC) for 72 h.
(O) Western blot analysis of indicated proteins from isolated pancreatic islets of 28-week-old db/db (Leprdb/db) or control (Lepr+/?) mice. Each line represents
pooled islets from three mice.
(P–R) Transcript levels of UPR-related genes from isolated islets of bJazf1KO and control mice (P), INS1E cells transfected with siRNAs targeting Jazf1 (si-Jazf1)
or control (si-Ctrl) (Q), or INS1E cells infected with control or Jazf1-expressing adenoviruses (R). n = 3 per group.
Data are presented asmean ±SD. *p% 0.05, **p% 0.01, and ***p% 0.001 by two-way ANOVAwith Holm-Sidakmultiple-comparisons test (A and B) or Student’s
t test (C–G and P–R).
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included Derl3, Creld2, Kdelr3, and the ER stress gene Ddit3
(Chop) (Figure 2P). One of the most upregulated ER stress-
related genes was Derlin-3, which is essential for the machinery
of the ERAD pathway by targeting misfolded proteins upon ER
stress (Oda et al., 2006). We measured increased levels of
several UPR-related genes upon knockdown of Jazf1 in INS1E
cells in untreated as well as TG-treated cells (Figures 2Q and
S2U). Importantly, overexpression of Jazf1 in primary dispersed
mouse islets (Figure 2R) or in INS1E cells (Figure S2V) in high-
glucose conditions revealed the opposite transcriptional
response. Furthermore, the same genes were upregulated in is-
lets of diabetic db/db mice (Figure S2W). These results demon-
strate a role of JAZF1 in ER stress responses and indicate that
decreased JAZF1 expression in b-cells may contribute to the
activation of ER stress pathways and ultimately apoptosis.
Genome-wide Identification of JAZF1 Targets by RNA
and ChIP Sequencing
In search of a molecular explanation for the ER stress/
apoptosis susceptibility of Jazf1-deficient b-cells, we per-
formed RNA sequencing (RNA-seq) on isolated islets of
bJazf1KO and bWt mice (Table S1). The transcriptome analysis
identified 2,637 significantly regulated genes with mild gene
expression changes (log2 fold change % 0.5, p % 0.01, false
discovery rate [FDR] < 0.05) upon deletion of Jazf1 (Figure S3A).
Hierarchical clustering on the basis of RNA levels identified two
major gene sets (Figure 3A), with 844 downregulated genes
(cluster A) and 693 upregulated genes (cluster B) in bJazf1KO
islets compared with b Wt littermates. Gene Ontology (GO)
analysis of cluster A identified enriched annotated gene prod-
ucts relating to histone and chromatin modification (Figure 3B).
Gene set B showed GO enrichment in nuclear-transcribed
mRNAs, mRNA catabolic processes, and protein translation
(Figure 3B). These results are consistent with JAZF1 as a prin-
cipal transcriptional regulator of ribosome biogenesis and func-
tional ortholog of Sfp1.
To confirm the transcriptional role of JAZF1 at the chromatin
level, we performed a genome-wide chromatin immunoprecipi-
tation (ChIP) sequencing (ChIP-seq) analysis of JAZF1 in pancre-
atic b-cells. Because no suitable antibody for ChIP was avail-
able, we infected cells with a recombinant adenovirus
expressing HA-tagged JAZF1 at a low MOI to perform ChIP. Af-
ter 24 h, Jazf1 transcript and protein levels were increased2.5-
fold compared with endogenous Jazf1 levels (Figures S3B and
S3C). ChIP analysis identified 316 target genes that were en-
riched mainly for proximal promoter regions (Figure 3C), as
shown by the majority of JAZF1 peaks occurring within 1 kb rela-
tive to the transcription start site (TSS) (Figure 3D; Table S2). To
identify putative biological processes for JAZF1 targets, we car-
ried out an enrichment analysis for GO and Kyoto Encyclopedia
of Genes and Genomes (KEGG) analysis and found that Jazf1
targets were enriched for biological processes such as transla-
tion, ribosome, mRNA splicing, chromatin remodeling, and regu-
lation of translation fidelity (Figures 3E and S3D). In line with our
RNA-seq data, the ChIP-seq analysis also supported JAZF1’s
role as a transcriptional regulator of ribosome biogenesis and
protein synthesis. Because sequence-specific DNA binding do-
mains for JAZF1 have not been identified, we used the de novo
motif discovery program MEME-ChIP (Machanick and Bailey,
2011) to identify sequence motifs that are overrepresented in
JAZF1 binding sites. Themost significant JAZF1-associatedmo-
tifs corresponded to consensus binding sites for the ETS domain
family transcription factors (E26 transformation specific), which
are unique to metazoans (Degnan et al., 1993). Of the 243
JAZF1 promoter binding sites, 63% contain at least one ETS
consensus motif CCGGAA (Figure 3F). ETS family transcription
factors interact with amultitude of co-regulatory partners to elicit
gene-specific responses and drive distinct biological processes
such as development, cell cycle, proliferation, and apoptosis (Oi-
kawa and Yamada, 2003). Additionally, JAZF1 has been shown
to function as a repressor of the direct repeat DNA element
(DR1)-dependent transcriptional regulation by Nr2c2 through
interaction with its LBD (Nakajima et al., 2004). Nr2c2 has been
implicated in both transcriptional activation and repression and
comprises the most abundant nuclear hormone receptor (NHR)
in pancreatic islets (Bookout et al., 2006; Chuang et al., 2008).
To examine the potential interaction between JAZF1 and
NR2C2, we performed immunoprecipitation followed by mass
spectrometry (IP-MS) in INS1E cells. IP-MS identified only
NR2C2 interacting with JAZF1 (Figure S2E; Table S3), a finding
that was validated with co-immunoprecipitation assays (Fig-
ure S2F). To identify NR2C2 elements in the promoters of
JAZF1 target, we used the NHR computational analysis program
‘‘NHR-scan’’ to predict NHR binding sites in genomic sequences
(Sandelin andWasserman, 2005). This analysis revealed that the
DR1 motif was overrepresented in the promoters of JAZF1 tar-
gets, with 29% of the peaks compared with other NHR motifs
(Figure 3G). The DR1 motif in JAZF1 binding sites was also
confirmed with MEME analysis (Figure 3F) and confirms ChIP-
seq studies of NR2C2 in four different non-b-cell lines that iden-
tified a DR1 motif in 30% of peaks (O’Geen et al., 2010). Further-
more, GO analysis of NR2C2 target genes was enriched in ribo-
some, translation, and RNA processing, similar to our ChIP
analysis of JAZF1 targets. Together, the integration of experi-
mental MS-IP, RNA-seq, and ChIP-seq data of JAZF1 and pub-
lished NR2C2 ChIP data (O’Geen et al., 2010) demonstrates that
the JAZF1/NR2C2 complex is a key transcriptional regulator of
ribosome biogenesis and protein translation.
Figure 3. JAZF1 Regulates Ribosomal Proteins and Aminoacyl-tRNA Synthetases
(A) Heatmap for hierarchical clustering of differential gene expression in isolated pancreatic islets from bJazf1KO and bWt mice (n = 3).
(B) Functional enrichment analysis of JAZF1 target genes on the basis of Gene Ontology terms for biological process (BP) of clusters A and B of RNA-seq data
from isolated islets from bJazf1KO and bWt mice.
(C) Representative diagram indicating the distribution of JAZF1 peaks in the genome.
(D) Distribution profile of peak distances relative to the transcription start site (TSS).
(E) Gene Ontology analysis of JAZF1 target genes.
(F and G) Motif analysis of JAZF1 binding site using MEME (F) and NHR scan analysis (G).




Figure 4. Loss of JAZF1 Function Leads to Impaired Protein Synthesis and rRNA Processing
(A–C) Protein synthesis, assessed via puromycin labeling, in islets of bJazf1KO and bWt control mice (A), Leprdb/db and littermate controls at 6 and 28weeks of age
(B), and human pancreatic islets cultured in the presence or absence of palmitate and cytokines (IL-1b, IFN-g, and TNF-a) for 72 h (C). Quantifications of total
puromycin protein levels normalized to actin; a total of four replicates (A and C) and three replicates (B) are shown below the images.
(D) Jazf1 expression in MIN6 cells following siRNA transfection and determined by qPCR (n = 3).
(legend continued on next page)




Impaired Protein Synthesis and rRNA Processing in
Jazf1-Null Mice
To investigate JAZF1’s involvement in protein synthesis and
ribosome biogenesis, we treated islets of bJazf1KO and control
mice with puromycin and measured the rate of protein synthesis
on the basis of the incorporation of puromycin to newly synthe-
sized proteins (Schmidt et al., 2009). Western blot analysis
showed decreased levels of translation in islets of bJazf1KO
compared with bWt mice (Figure 4A). We also studied islets of
prediabetic and diabetic Leprdb/db mice at the ages of 6 and
28 weeks, respectively, and found increased protein synthesis
at 6 weeks of age, when b-cells compensate for insulin resis-
tance by hypersecretion of insulin and b-cell replication (Cava-
ghan et al., 2000; Rhodes, 2005). However, at 28 weeks of
age, the ratio of protein synthesis in Leprdb/db islets was
decreased compared with 6-week-old Leprdb/db mice (Fig-
ure 4B). These age-dependent alterations in protein synthesis
correlate with the well-known compensatory and decompensa-
tory phases of b-cells in diabetes development (Weir and Bon-
ner-Weir, 2004). The data are also in consistent with the pro-
found decrease in protein translation when b-cells are exposed
to experimental ER stress (Figure S4A). Protein synthesis was
also decreased in human islets that were exposed palmitic
acid and a CC and high-glucose conditions for 72 h (Figure 4C).
These results demonstrate that JAZF1 expression or activity is
required for normal translation of b-cell proteins in physiological
and metabolic stress conditions.
We next asked whether JAZF1 might be involved in ribosome
biogenesis, thereby providingmechanistic insights linking loss of
JAZF1 function and altered protein synthesis. This possibility
was tested by silencing JAZF1 in MIN6 cells using small inter-
fering RNAs (siRNAs), leading to a80% reduction of Jazf1 tran-
script levels (Figure 4D), and assessing the processing of the ri-
bosomal subunit precursor RNAs by northern blotting using
three different probes: ETS (transcription of 47S rRNA), ITS1
(processing of 18S), and ITS2 (processing of 28S) (Figure 4E).
We found that the transcription of 47S rRNA was not affected
in Jazf1-depleted cells versus control cells (Figure 4F), but the
ITS1 probe revealed a significant accumulation of 45/47S and
41S pre-rRNAs and decreased levels of 30S and 21S pre-rRNAs
(Figure 4G). Furthermore, we noted a significant accumulation of
18S-E pre-rRNA in Jazf1-depleted cells, indicating that the last
step of 18S rRNA processing was impaired. Similar results
were found with the ITS2 probe, revealing an enrichment of
45S and 41S pre-rRNAs but not the 12S pre-rRNA precursor
following knockdown of Jazf1 (Figures 4G–4I). Importantly, we
found a similar defect in rRNA processing in islets of Leprdb/db
mice compared with Lepr+/? islets (Figure 4J), suggesting that
rRNA processing may be impaired in T2D. In order to determine
the impact of this alteration at the level of the ribosome, we per-
formed a polysome profiling analysis in MIN6 cells in which Jazf1
levels were reduced by RNAi. JAZF1-depleted cells exhibited a
lower abundance of free 40S subunits, which contains mature
18S rRNA, and a consequent decrease of 80S ribosomes and
polysomes compared with control siRNA-transfected cells (Fig-
ure 4K). As alterations in ribosome biogenesis are often associ-
ated with changes in the morphology of nucleoli (Mélèse and
Xue 1995; Boulon et al., 2010), we stained cells with anti-fibril-
larin, a nucleolar protein involved in pre-rRNA processing, to
monitor the nucleolus size. Silencing of Jazf1 resulted in larger
nucleoli, as determined by an increased ratio between nucleolar
and nuclear areas, suggesting a direct correlation between
nucleolar size and rRNA processing upon Jazf1 knockdown (Fig-
ures 4L and 4M). Collectively, these results indicate that JAZF1
plays an important role in pre-rRNA processing by facilitating
the formation of 18S rRNA and ribosomal 40S subunits and
thereby regulating protein synthesis.
JAZF1 Regulates the Expression of rRNA Processing
and Ribosomal Protein Genes and Influences p53-
Dependent Stress Responses
To identify the genes that could mediate the defect in rRNA pro-
cessing, we queried RNA-seq data from bJazf1KO and bWtmice
for expression changes in transcripts encoding ribosome
biogenesis factors. We found significantly dysregulated genes
that are involved in rRNA processing (Figure 5A). We examined
two factors, respectively, that are upregulated (Tsr3, Nop56)
and downregulated (Nol4, UTP14C) in islets of bJazf1KO mice.
Silencing of Nol4 and UTP14C in MIN6 cells had no effect on
rRNA processing (Figure S5A). Tsr3 overexpression led to
abnormal 18S rRNA processing compared with control cells
(mCherry) when probed with ITS1 (Figures 5B and S5B). Similar
defects in pre-rRNA processing were found when we overex-
pressed Nop56 in MIN6 cells (Figure 5C). Tsr3 catalyzes the
base modification of 18S rRNA (Meyer et al., 2016), whereas
Nop56 is a component of the box C/D small nucleolar ribonu-
cleoprotein complexes that direct 2-prime-O-methylation of
pre-rRNAs during its maturation and therefore may function in
an early to middle step of pre-rRNA processing (Hayano et al.,
2003). Whereas we did not detect an enrichment of JAZF1 at
the Tsr3 promoter, our ChIP analysis revealed that JAZF1 binds
to the promoter region of Nop56 (Figure 5D).
Defects of rRNA modifications or processing enzymes often
lead to disturbed ribosome biogenesis or assembly (King et al.,
2003; Liang et al., 2009). This in turn can activate cellular stress
responses, including activation of the p53 pathway, a process
(E) Schematic illustration of pre-rRNA processing. Cleavage sites to remove external and internal spacers (ETS/ITS1/2) are indicated.
(F–H) Northern blot analysis of MIN6 cells transfected with si-Jazf1 and control siRNAs and hybridized with ETS (F), ITS1 (G), or ITS2 (H) probes.
(I) Densitometric analysis of the pre-rRNA of 18S (ITS1 probe) and 28S (ITS2 probe) of MIN6 cells transfected with si-Jazf1 and control siRNAs (n = 4).
(J) Northern blot analysis of isolated islets from Leprdb/db and wild-type mice, hybridized with the indicated probes.
(K) Polysome profiling analysis of MIN6 cells transfected with si-Jazf1 and control siRNAs.
(L and M) Immunohistochemical staining of nucleolar protein fibrillarin and DNA (DAPI) in MIN6 cells transfected with si-Jazf1 and control si-RNAs (L) and
quantification of stained fibrillarin/DAPI area (M). Scale bar: 10 mm (n = 3).
Data are presented asmean ±SD; *p% 0.05, **p% 0.01, ***p% 0.001, and ****p% 0.0001 by two-way ANOVA (Sidak’s multiple-comparison test) (I) or Student’s
t test (A–D and M).
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named ‘‘ribosomal stress’’ (Boulon et al., 2010; Wang et al.,
2015). We elicited ribosomal stress by treating MIN6 cells with
low doses of actinomycin D, known to selectively inhibit RNA po-
lymerase I (Perry and Kelley, 1970), which resulted in decreased
protein translation and a strong activation of p53 and apoptosis
(Figure S5C). Interestingly, increasedNop56 expression was suf-
ficient to impair protein translation and activate p53 and its target
p21 (Figure 5E), whereas Tsr3 overexpression had no effect on
protein translation but was sufficient to activate p53 (Figures
S5D and S5E). These data show that JAZF1 directly and indi-
rectly regulates rRNA biogenesis factors that alter pre-rRNA pro-
cessing and stimulate ribosomal stress responses.
Our transcriptomic analysis in bJazf1KO mice revealed
increased levels of several 40S and 60S ribosomal protein (RP)
genes compared with bWt mice (Figure 5F). In line with the
RNA-seq data, ChIP-seq analysis showed that JAZF1 binds to
the promoters of five small (40S) and nine large (60S) RP genes
(Figure 5G). Interestingly, the levels of RPs are not affected in is-
lets of prediabetic Leprdb/db mice, when Jazf1 expression is un-
changed, but in older diabetic Leprdb/db mice, when Jazf1
expression was reduced by 50%, RPs were significantly
increased compared with WT controls (Figures 1C and 5H).
These findings are consistent with recent studies showing
increased expression of RP genes in islets from Leprdb/db mice
(El Ouaamari et al., 2015).
We next studied the transcriptional regulation of selected
JAZF1-targeted RPs by perturbing JAZF1 levels using lucif-
erase reporter assays. We first confirmed the reduced levels
of Rpl10 in islets of bJazf1KO mice (Figure S5F) and found
that overexpression of JAZF1 resulted in increased Rpl10 pro-
moter activity. This regulation was dependent on an intact
Nr2c2 element in the promoter of Rpl10 and supports the nega-
tive regulation of JAZF1 on this promoter (Figures 5I and 5J).
Conversely, the Rps14, which is also a direct JAZF1 target
and overexpressed in islets of bJazf1KO mice (Figures 5F and
S5G), showed decreased transcript levels when Jazf1 was
overexpressed and increased expression upon silencing of
Jazf1 (Figure S5H), which corroborates the upregulation in is-
lets of diabetic Leprdb/db mice (Figure 5H). This JAZF1 tran-
scriptional control was also dependent on an Nr2c2 element
in the Rps14 promoter (Figure S5I).
The observed ribosome defects in bJazf1KOmice led us to hy-
pothesize that the ‘‘disturbance’’ of ribosome subunit compo-
nents induces an ‘‘imbalance state’’ in the cell, activating the
p53 pathway and consequently cell-cycle arrest, thereby influ-
encing proliferation and apoptosis (Zhang and Lu, 2009; Warner
and McIntosh, 2009). To explore if the silencing of Rpl10 and
overexpression of various RPs in bJazf1KO islets can activate
the p53 pathway, we knocked down Rpl10 and overexpressed
RPs of the small and large subunit in INS1E cells. Both silencing
of Rpl10 and overexpression of Rps-11, Rps-14, Rps-15,
Rpl10a, and Rpl12 activated the p53 pathway (Figures 5K and
5L). These findings indicate that JAZF1 is required for tight con-
trol of rRNA processing and RP transcription and for the coordi-
nation of these processes with cell survival pathways.
JAZF1 Regulates Aminoacyl-tRNA Synthetases
Our ChIP-seq analysis demonstrated that JAZF1 binds to the
promoters of seven aminoacyl-tRNA synthetase genes (aaRSs)
(Figure 6A), consistent with the KEGG analysis of JAZF1 target
genes revealing that ‘‘aaRSs’’ ranked second in the enrichment
gene sets after ‘‘ribosome’’ (Figure S3D). aaRSs are composed
of 20 different ligases that catalyze the ligation of a specific
amino acid to its cognate tRNA, thereby ensuring the fidelity of
protein synthesis (Ibba and Söll, 2000). The expression levels
of two aaRSs, aspartyl-tRNA synthetase (Dars) and glycyl-
tRNA synthetase (Gars), were decreased in islets from bJazf1KO
compared with bWt mice (Figure 6B) and JAZF1 was found in
ChIP studies to bind to their respective promoter regions (Fig-
ures 6C and 6D). Moreover, silencing of Jazf1 in INS1E cells re-
sulted in lower mRNA levels of Gars and Dars compared with si-
control-transfected cells (Figure 6E). Adenoviral overexpression
of Jazf1 elicited the opposite transcriptional regulation of Dars
and Gars compared with Ad-GFP-infected cells (Figure 6F).
Furthermore, transcript levels of Dars andGars were significantly
decreased in islets of diabetic Leprdb/db mice (Figure 6G). Of
note, in humans, the mRNA levels of Gars are themost highly ex-
pressed in pancreas compared with other tissues (Antonellis
et al., 2003) and further enriched in b-cells (Park et al., 2010).
To investigate if reduced expression of Dars and Gars can be
linked to ER stress and activation of cell death pathways, we
silenced these aaRSs in the presence and absence of ER stress.
Figure 5. JAZF1 Regulates rRNA Processing and Ribosomal Protein Transcription
(A) Expression levels of pre-rRNA processing genes in islets of bJazf1KO and bWt control mice (n = 3).
(B and C) Northern blot analysis of MIN6 cells transfected with expression plasmids for Tsr3 (B) and Nop56 (C) and hybridized with indicated probes. mCherry
plasmid was used as a control.
(D) Genome Browser tracks of ChIP-seq peaks in INS1E cells. Region spanning the Nop56/Idh3B genes on chromosome 3 is shown. ChIP-seq peaks are
presented after normalizing to input.
(E) Western blot analysis of indicated proteins in MIN6 cells transfected with Nop56 and control (mCherry) expression plasmids. Protein synthesis was assessed
using puromycin labeling.
(F) Heatmap of ribosomal gene expression in islets of bJazf1KO and bWt mice.
(G) Peak enrichment of JAZF1 on promoters of indicated ribosomal proteins of 40S and 60S subunits in INS1E cells.
(H) Heatmap of relative ribosomal gene expression in islets of Leprdb/db and control mice at 6 and 28 weeks of age.
(I) Genome Browser tracks of ChIP-seq peaks in INS1E cells. Region spanning the Dnase1I1/Rpl10 genes on the X chromosome is shown.
(J) Luciferase reporter assay of INS1E cells transfected with plasmids containing wild-type (WT) Rpl10 promoter or a mutated Nr2c2 site (mutant) and infected
with either a control or Jazf1-expressing adenovirus (Ad-Jazf1). Levels are relative to Renilla luciferase activity (n = 5).
(K and L) Western blot analysis of indicated proteins in INS1E cells transfected with si-Rpl10 or control siRNAs (K) or expression plasmids of indicated myc-
tagged ribosomal genes (L).
Data are presented asmean ±SD; *p% 0.05, **p% 0.01, ***p% 0.001, and ****p% 0.0001 by two-way ANOVA (Sidak’smultiple-comparison test) (J) or Student’s
t test (A).




Figure 6. JAZF1 Regulates the Expression of Aminoacyl-tRNA Synthetase Genes
(A) Peak enrichment of JAZF1 in ChIP-seq analysis of INS1E cells on promoters of indicated aminoacyl-tRNA synthetase genes.
(B) Relative expression levels of Gars and Dars in islets of bJazf1KO and bWt control mice (n = 3).
(C and D) Genome Browser tracks of ChIP-seq peaks in INS1E cells. Regions spanning the Gars (C) and Dars (D) genes, respectively, are shown. ChIP-seq peaks
were normalized to input.
(legend continued on next page)




No evidence for ER stress was observed upon Gars knockdown,
but wemeasured increased phosphorylation of eIF2awhen Dars
was silenced (Figure 6H). This finding underlines recent reports
suggesting that deficiency states of aaRSs are linked to the ER
stress response (Krokowski et al., 2013; Fröhlich et al., 2017).
Moreover, knockdown of Dars and Gars rendered the suscepti-
bility to apoptosis upon exposure to ER stress (Figures 6I and
6J). Together, these findings show that JAZF1 is a positive and
direct transcriptional regulator of aaRSs, which play a crucial
role in translation and ER stress-mediated apoptosis of pancre-
atic b-cells.
Srp54a and Insulin Are Direct Targets of JAZF1
SRP54a is a key component of the ribonucleoprotein complex
that interacts with ribosomes to bring the translocation of secre-
tory and membrane proteins to the ER (Focia et al., 2004). We
noted that Srp54a transcript levels were 2-fold lower in islets of
bJazf1KO mice compared with controls (Figure 7A). Our ChIP-
seq data further demonstrated that JAZF1 binds to the Srp54a
promoter region (Figure 7B). Recently, it has been shown that
mutations in SRP54a cause Shwachman-Bodian-Diamond syn-
drome, a recessive disease characterized by exocrine pancre-
atic insufficiency, bone marrow failure, and skeletal dysplasia,
but may also present with early infancy diabetes (Kamoda
et al., 2005). Loss-of-function mutations and knockdown of
SRP54a have been shown to induce ER stress and are associ-
ated with apoptosis in human bone marrow cells (Bellanné-
Chantelot et al., 2018). Interestingly, we found that Srp54a levels
are increased and reduced in islets fromprediabetic and diabetic
Leprdb/db mice, respectively, compared with control mice (Fig-
ure 7C). Moreover, knockdown of Srp54a in INS1E cells induced
the phosphorylation of eIF2a and increased levels of cleaved
caspase-3 (Figure 7D). These data indicate that JAZF1 partici-
pates in the regulation of SRP54a expression, which plays a
crucial role in ER stress-mediated apoptosis of b-cells.
Our ChIP-seq data also identified enriched binding of JAZF1 at
the proximal promoter region of the Ins1 gene (Figure 7E).
Furthermore, the NHR scan analysis identified a direct repeat
(DR1) Nr2c2 element located at 61 to 49 bp relative to the
TSS and contained the consensus hexanucleotide sequence
AGGTCA. Importantly, this element is conserved among mouse,
rat, and human genomes (Figure S6A). In the human promoter, it
is located between nucleotide positions276 and264 bp rela-
tive to the TSS. Of note, this motif is located in the previously
described glucose-responsive element (Z element) (292 to
243 bp) that acts both as a glucose-responsive enhancer in pri-
mary cultured islet cells and as a transcriptional repressor in
immortalized b- and non-b-cells (Sander et al., 1998; Pino
et al., 2005).
Our RNA-seq and qPCR analysis revealed that the transcript
levels of Ins1 were increased in islets of bJazf1KO compared
with bWtmice, whereas Ins2 mRNA levels were unchanged (Fig-
ure 7F). In addition, INS1E cells infected with a Jazf1-expressing
adenovirus had reduced levels of Ins1 compared with cells in-
fected with a control virus (Figures 7G and 7H). Overexpression
of Jazf1 in dispersed human islet cells resulted in decreased INS
transcript levels compared with control (Ad-GFP) infected cells
(Figure 7I), indicating that the transcriptional regulation of the
INS gene by JAZF1 is conserved between rodents and human.
To determine if JAZF1 regulates human insulin gene transcrip-
tion through the NR2C2 DR1 element, we generated three lucif-
erase reporters with upstream human insulin promoter se-
quences (WT), or identical constructs harboring point
mutations (mutant), or a deletion of the NR2C2 DR1 motif (Fig-
ure 7J). These reporter constructs were transfected into En-
doC-bH2 human cells in which JAZF1 was either present or
silenced by RNAi. The basal activity of the human insulin pro-
moter was increased in Jazf1-depleted cells. Remarkably, this
activation was abolished in reporter plasmids harboring a
NR2C2 mutant or deletion element (Figure 7K), indicating that
the DR1 element is required for the regulation of the human insu-
lin gene by JAZF1. Of note, bJazf1KO mice exhibited higher
levels of serum proinsulin compared with bWt animals, an obser-
vation that is in agreement with the higher proinsulin levels found
in human and rodent T2D. These results demonstrate key roles
for JAZF1 in protein translation by transcriptional regulation of
Srp54a, a protein that links three key elements of the SRP com-
plex (i.e., the 7SL RNA, the signal sequence of the nascent ribo-
some-bound polypeptide chain, and the signal peptide receptor
on the ER membrane), as well as the insulin gene through a
conserved negative regulatory element (NRE) containing a DR1
site in the INS promoter, whose mechanistic basis of repression
has remained elusive.
DISCUSSION
In this studywe confirm in a large cohort that the SNP rs1635852,
located in intron X of JAZF1, is a T2D susceptibility gene.
Rs1635852 is located in a key region of a b-cell enhancer and
mediates allele-specific differences in JAZF1 expression, with
the T2D risk allele T exhibiting lower transcriptional activity
than the nonrisk allele C. Furthermore, the risk allele also medi-
ates increased binding to protein complexes involving JAZF1,
suggesting that it functions as part of a transcriptional repressor
complex (Fogarty et al., 2013). Our study also demonstrates that
JAZF1 is a key factor in pancreatic b-cells for sensing metabolic
stress signals and for mediating a dynamic and coordinated
transcriptional response that regulates protein translation in
response to increased insulin demand. JAZF1 is enriched in
b-cells and dynamically distributed in the cytoplasm and nu-
cleus, with a predominantly cytosolic localization with low
glucose in mice and healthy human subjects and a nuclear pres-
ence upon stimulation with high glucose and in different murine
models (Akita, db/db) and in pancreatic sections of patients with
(E–G) Expression levels of Gars and Dars in INS1E cells upon silencing using siRNAs (E) or overexpression of Jazf1 (Ad-Jazf1) compared with control cells (Ad-
GFP) (F) and in islets of Leprdb/db and control mice (Lepr+/?) at 6 and 28 weeks of age (G). n = 3 per group.
(H–J) Western blot analysis of eIF2a (Ser51), eIF2a (H) and cleaved caspase-3 (I and J) in INS1E cells following transfection of siRNAs targeting Dars (H and I) or
Gars (J) in response to thapsigargin (TG) for 5 h. Quantification of band intensities by densitometry are shown on right. All data are in duplicates.
Data are presented as mean ± SD; *p% 0.05, **p% 0.01, ***p% 0.001, and ****p% 0.0001 by Student’s t test.
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T2D. Although our mouse genetic studies show that JAZF1 is
dispensable for normal b-cell function, it is clear that during
increased insulin demand or b-cell growth, JAZF1 translocates
to the nucleus, thereby influencing the transcription and the
expression of its target genes. The mechanisms by which
JAZF1 translocates to the nucleus during metabolic stress may
be mediated by increased Ca2+ levels, induced by high glucose
and/or cytokine signaling, or by a calcineurin-mediated process
that dephosphorylates JAZF1, thereby exposing nuclear import
signals leading to translocation in the nucleus, where Jazf1 reg-
ulates transcription (Cartwright and Helin, 2000). This model is
supported by several conserved phosphorylated serine and
tyrosine residues in JAZF1. It will be important to determine
the kinases and phosphatases that regulate stress- and
glucose-mediated nuclear import in pancreatic b-cells. We
show that in diabetic states, the nuclear shuttling of JAZF1 in
b-cells is intact, but the overall expression levels are significantly
reduced in diabetic rodents, in islets of T2D patients, and in islets
exposed to chronic metabolic stress, findings that support a
study reporting reduced JAZF1 levels in human islets of hyper-
glycemic donors (Taneera et al., 2012). These results indicate
that in chronic stress conditions, JAZF1 function is impaired,
contributing to progressive b-cell dysfunction as shown in Akita
bJazf1KO mice that have a markedly accelerated disease pro-
gression due to increased b-cell apoptosis and decreased prolif-
eration (Figure 7L).
Our analysis of ChIP-seq and RNA-seq revealed that JAZF1 is
a transcriptional mediator of ribosome biogenesis, including 40S
and 60S subunit genes, rRNA processing, and aaRSs, and that
these processes are impaired in murine T2D (Figure 7L). These
findings are consistent with RNA-seq analysis from islets of hu-
man T2D showing ribosome biogenesis transcripts as the most
enriched gene set (De Jesus et al., 2019; Li et al., 2018). Our
data are also consistent with JAZF1 being an ortholog of yeast
Sfp1, a master transcriptional regulator of ribosome biogenesis
in yeast (De Virgilio and Loewith, 2006).
Our morphometric analysis of nucleoli revealed that their size
is enlarged in Jazf1-depleted b-cells, and their shape remained
intact. This appearance resembles what has been seen in aging
cell culture models and in senescent cells (BeMiller and Lee,
1978; Bowmann et al., 1976). Conversely, small nucleoli are a
cellular hallmark of longevity in mutant as well as calorie-
restricted organisms, which also exhibit decreased expression
of ribosomal RNA and proteins, including fibrillarin (Tiku et al.,
2017). Recent evidence suggests additional roles for nucleoli
as key hubs for sensing and reacting to various stress stimuli
such as induction of senescence, DNA damage by activating
the p53 pathways, cell-cycle arrest, and apoptosis (Deisenroth
et al., 2016). Furthermore, nucleolar stress and p53 activation,
both present in islets of diabetic bJazf1KO mice, have also
been associated with increased nucleoli size (James et al.,
2014). The increased nucleolar size in b-cells that are depleted
in JAZF1 are therefore consistent with these published reports
but may be attributed to the increased synthesis of RP, as 1/
3 of all nucleolar proteins detected by mass spectrometry are
composed of RPs (Boisvert et al., 2007; Lam et al., 2010).
One of the most striking results of our study is the finding that
in response to experimental conditions of ER stress, Jazf1 tran-
scripts and nuclear protein levels are reduced, leading to
increased ER stress and susceptibility to apoptosis. Data from
mutant Jazf1 mice also show that JAZF1 contributes to ER ho-
meostasis. Previous studies have shown that increased protein
synthesis can lead to upregulation of the UPR pathway through
accumulation of misfolded proteins (Harding et al., 2000a,
2000b; Ron, 2002). We found that deletion of Jazf1 induces the
expression of UPR-related genes, whereas Jazf1 overexpres-
sion elicits the opposite transcriptional response. We implicate
three processes in leading to the activation of ER stress in the
absence of JAZF1: impaired rRNA processing, abnormal RP
expression, and defective transcriptional regulation of tRNAs.
The observed defect in rRNA processing upon in bJazf1KO
mice can be predicted to affect ribosome assembly and protein
production. Moreover, we uncover a previously unrecognized
defect in rRNA processing and translation in islets from db/db
mice at the decompensation stage. Our RNA-seq and ChIP-
seq analysis further indicate that the gene encoding Nop56,
which is a direct JAZF1 target, is responsible for the impairment
in rRNA processing, as overexpression of Nop56 in b-cells led to
Figure 7. JAZF1 Is a Transcriptional Regulator of the SRP54a and INS Genes
(A) Srp54a transcript levels of bJazf1KO and bWt control mice. n = 3 per group.
(B) Genome Browser tracks of ChIP-seq peaks in INS1E cells. Region spanning the Srp54a gene and its promoter is shown. ChIP-seq peaks are presented after
normalizing to input.
(C) Expression of Srp54a in islets of 6- and 28-week-old Leprdb/db and wild-type control mice.
(D) Western blot of indicated proteins in INS1E cells following transfection with si-Srp54a or si-Ctrl. Actin was used as a loading control.
(E) Genome Browser tracks of ChIP-seq peaks in INS1E cells. Approximately 20 kb region spanning the murine Ins1 locus is shown on chromosome 1. ChIP-seq
peaks are presented after normalizing to input.
(F) Relative expression levels of Ins1 and Ins2 in islets of bJazf1KO and bWt mice.
(G–I) Relative expression of Jazf1 (G) and Ins1 (H) in INS1E cells, and INS (I) in dispersed human islets following Ad-Jazf1 or control Ad-GFP infection. n = 3 per
group.
(J) Schematic representation of reporter plasmids harboring the human insulin promoter with wild-type, mutant, or a deleted DR1 element site. TSS, transcription
start site.
(K) Luciferase activity assays in Endoc-bH2 cells transfected with firefly luciferase reporter constructs shown in (J). Data are normalized to Renilla luciferase. n = 5
for each group.
(L) Illustration of model depicting the role of JAZF1 in normal (green) conditions and in response to short (orange) and chronic (red) exposure to metabolic stress.
Bottom: illustration of model showing the molecular function of JAZF1 in active (nuclear) conditions.
Data are presented asmean ±SD; *p% 0.05, **p% 0.01, ***p% 0.001, and ****p% 0.0001 by two-way ANOVA (Sidak’smultiple-comparison test) (K) or Student’s
t test (A, C, and F–I).




defect in 18S and 28S processing. This finding is in line with a
recent study demonstrating that knockdown or overexpression
of Nop56 results in defects in pre-rRNA processing (Lykke-An-
dersen et al., 2018).
We also discovered that JAZF1 is a prominent regulator of
numerous RPs and demonstrate that JAZF1 is responsible for
maintaining the balance between the components of ribosomal
subunits (rRNA and RPs) for optimal ribosome synthesis. Abla-
tion of Jazf1 in islets revealed increased levels of many RP tran-
scripts, accompanied by a reduction in the 40S subunit, indi-
cating that JAZF1 is primarily a negative transcriptional
regulator of RPs. Our data therefore offer a mechanistic explana-
tion for a recent study reporting increased levels of subsets of
RPs in a rat T2D model compared with control islets using unbi-
ased quantitative proteomic analysis (Hou et al., 2017). An
emerging body of literature suggests that rRNA processing and
ribosome biogenesis are tightly orchestrated processes and
that imbalances in synthesis or turnover can affect signaling
pathways and disease development. Furthermore, these path-
ways are linked to p53 activation as a general response to defec-
tive ribosome function (Barlow et al., 2010; Dutt et al., 2011). For
example, Rps6 haploinsufficiency activates the p53 pathway in
mouse embryonic cells and T lymphocyte cells (Sulic et al.,
2005). Zebrafish with a heterozygous Rpl11 mutation exhibit
increased glucose levels and upregulated preproinsulin tran-
script level (Danilova et al., 2011). Furthermore, conditional inac-
tivation of Rps14 in mice leads to a p53-dependent erythroid dif-
ferentiation defect (Schneider et al., 2016). Interestingly,
overexpression or silencing of single RPs is sufficient to affect
ribosome biogenesis and induce activation of the p53 pathway
(Lohrum et al., 2003; Zhou et al., 2013). We show that silencing
or overexpression of the JAZF1 targets Rpl10 and Rps14 is suf-
ficient to perturb protein synthesis and induce p53 activation and
apoptosis. Of note, GWASs have identified an association be-
tween p53 and T2D susceptibility (Gaulton et al., 2008; Burgdorf
et al., 2011), which is consistent with our and other studies
showing evidence of DNA damage and p53 activation in islets
of db/db mice and human T2D subjects (Tornovsky-Babeay
et al., 2014; Belgardt et al., 2015). Together, our study describes
a previously unrecognized mechanism in T2D in which defective
ribosome synthesis during metabolic stress activates p53 and
apoptosis in b-cells.
In this study, we show that JAZF1 is a direct transcriptional
activator of genes encoding aminoacyl tRNA synthetases. Muta-
tions in tRNA ligases frequently give rise to diseases with
neuronal pathologies and autoimmune and metabolic disorders.
Specifically, mutations in glycine tRNA ligase (GARS) are associ-
ated with childhood neuropathological diseases alongside
altered mitochondrial protein and respiratory chain subunit
expression (Boczonadi et al., 2018). Our finding that GARS levels
are reduced by 50% in db/dbmice and that silencing of Gars and
Dars renders b-cells more sensitive to ER stress-mediated
apoptosis corroborates phenotypic traits in mice with mutated
tRNA synthetase exhibiting impaired translational fidelity, protein
misfolding, and induction of ER stress (Lee et al., 2006).
Our study demonstrates that JAZF1 is a direct transcriptional
activator of Srp54a, a component of the signal recognition par-
ticle complex that is recognized by the signal sequence of the
nascent polypeptide on the ribosome and docked to the ER
membrane via the conjugate receptors. In b-cells, Srp54a binds
to the preproinsulin signal sequence appearing from the ribo-
some and slows down protein synthesis, which can prevent
the premature initiation of preproinsulin folding prior to nascent
peptide to the ER membrane (Eskridge and Shields, 1983; Wal-
ter and Blobel, 1983). We show that deletion of Srp54a leads to
increased phosphorylated eIF2a levels and induces apoptosis.
Importantly, Srp54a levels were decreased in absence of
JAZF1; furthermore, Srp54a expression was reduced in islets
of db/db mice where chronic ER stress is induced. Interest-
ingly, five mutations located in the preproinsulin signal peptide
have been reported to cause diabetes in humans (Støy et al.,
2007; Garin et al., 2010). Collectively, we propose that under
chronic insulin demand, in conditions of partial or absolute
JAZF1 deficiency, JAZF1 contributes to ER stress through
increasing insulin transcription directly and through defective
expression of Srp54, which can lead to cytosolically misas-
sembled, misfolded, and mislocalized proteins (Bellanné-Chan-
telot et al., 2018).
Insulin is a major ER client protein in b-cells, and high levels of
misfolded insulin protein can affect the protein folding capacity
and elicit ER stress. Interestingly, the serum proinsulin level
and proinsulin/insulin ratio were higher in Akita bJazf1KO mice
compared with Akita bWt mice. Previously, it has been shown
that the proinsulin/insulin ratio is increased in Akita mice, which
exhibit high levels of ER stress in b-cells (Winnay et al., 2014).
This observation is consistent with elevated proinsulin/insulin ra-
tios in human T2D (Ward et al., 1987; Vangipurapu et al., 2015)
and with studies demonstrating that proinsulin misfolding is an
early feature in the progression of prediabetes (Liu et al., 2005;
Arunagiri et al., 2019). Furthermore, transgenic insulin-overex-
pressing mice exhibit glucose intolerance in the absence of
obesity (Shanik et al., 2008), and insulin-knockout mice are
partially protected from chronic ER stress in b-cells (Szabat
et al., 2016). These data indicate that JAZF1 can alleviate ER
stress by reducing insulin synthesis, a notion that is supported
by the phenotype of transgenic Jazf1 mice that have reduced
fasting plasma insulin levels and enhanced glucose tolerance
(Yuan et al., 2015).
In this context and on the basis of our gene expression anal-
ysis from mutant JAZF1 in human and rodent islets and further
supported by the JAZF1 ChIP-seq analysis, it is relevant that
we also found the insulin promoter to be a direct JAZF1 target.
JAZF1 binds to a conserved DR1 site in the Ins1 promoter, which
is absent in Ins2 due to a nucleotide substitution. These observa-
tions are consistent with the transcriptional regulation of Ins1 but
not Ins2. Interestingly, in humans, we identified a DR1 site in the
insulin promoter within a previously described inhibitory
sequence (279 to 258), also referred to as the NRE (Boam
et al., 1990; Clark et al., 1995). This element also lies within the
glucose-sensing Z element (243 to 292) (Sander et al.,
1998; Pino et al., 2005), which functions as an enhancer in pri-
mary islet cells but represses transcription in immortalized
b-cells. Furthermore, the direct regulation of the insulin gene
by JAZF1 might contribute to the low insulin content of trans-
formed b-cell lines and act as a protective mechanism to coun-
teract glucose toxicity by downregulating insulin secretion




during chronic hyperglycemia and thereby relieving ER stress
and facilitating cell survival.
In summary, our study reveals JAZF1 as an important regu-
lator of ER stress and ribosome biogenesis via a feedback action
preventing the activation of ER and p53 stress-mediated b-cell
apoptosis. These findings further highlight the crucial influence
of JAZF1 on b-cell function. Finally, modulating JAZF1 activity
may be a potential pharmacological strategy to alleviate b-cell
stress and promote b-cell survival in T2D.
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REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Monoclonal Rabbit Anti-Jazf1 This paper N/A
Monoclonal Mouse Anti-Jazf1 Santa Cruz Cat# sc-376503, RRID: AB_11149923
Polyclonal Rabbit Nr2c2 Sigma Cat#HPA006313, RRID: AB_1079503
Monoclonal Rabbit Anti-Phospho eIF2a
(ser51)
Cell signaling Cat#3398, RRID: AB_10829234
Monoclonal Rabbit Anti-eIF2a Cell signaling Cat# 5324, RRID: AB_10692650
Polyclonal Rabbit Anti-Phospho Perk
(Thr981)
Santa Cruz Cat# sc-32577, RRID: AB_2293243
Monoclonal Rabbit Anti-BiP Cell signaling Cat#3177, RRID: AB_2119845
Monoclonal Mouse Anti-Ki67 BD Biosciences Ca#556003, RRID: AB_396287
Monoclonal Rat Anti-BrdU Abcam Cat#ab6326, RRID: AB_305426
Polyclonal Rabbit Anti-Cleaved Caspase 3 Cell Signaling Cat#9661, RRID: AB_234118
Polyclonal Rabbit Anti-phospho p53 (Ser15) Cell Signaling Cat#12571S, RRID: AB_2714036
Monoclonal Mouse Anti-p53 Santa Cruz Cat#sc-126 RRID: AB_628082
Monoclonal Mouse Anti-g-Tubulin Sigma Cat#T6557, RRID: AB_477584
Monoclonal Rabbit Anti-b-Actin Cell Signaling Cat#4970, RRID: AB_2223172
Monoclonal Rabbit Anti-P21 Abcam Cat#ab109199, RRID: AB_10861551
Monoclonal Mouse Anti-Puromycin Merck Millipore Cat#MABE343, RRID: AB_2566826
Polyclonal Rabbit Anti-Myc-tag Cell Signaling Cat#2272, RRID: AB_10692100
Monoclonal Mouse Anti-Mdm2 Santa Cruz Cat#sc-965, RRID: AB_627920
Polyclonal Guinea Pig Anti-Insulin Dako Cat#A056401 RRID: AB_2617169
Hoechst 33342 Thermo Fischer Scientific Cat#H3570
Chemicals, Peptides, and Recombinant Proteins
D-glucose anhydrous Sigma Cat#49139
BrdU Sigma Cat# B5002
Insulin solution Sigma Cat#I9278
Histopaque-1077 Sigma Cat#10771
Liberase Sigma Cat#05401127001
Lipofectamine 2000 Invitrogen Cat#11668500
Lipofectamine RNAiMAX Invitrogen Cat#13778-075
Trypsin Promega Cat#V5111
Phosphatase inhibitor Thermo Fisher Cat# 78427
Protease Inhibitor Sigma Cat#5056489001









Sodium Palmitate Sigma Cat#P9767
BSA (Fatty acid Free) Sigma Cat#A8806
(Continued on next page)





REAGENT or RESOURCE SOURCE IDENTIFIER
g32P-ATP Perkin Elmer NEG035C00MC
Nitrocellulose membrane Perkin Elmer NBA083C001EA
Amersham Hybond-N+ GE healthcare RPN2023B
Commercial Assays
Insulin ELISA ALPCO Cat#80-INSRTU-E10-AL
Proinsulin ELISA Mercodia Cat#10-1232-01
TUNEL Assay Millipore Cat#S7165
Deposited Data
RNA sequencing This paper PRJNA595139
ChIP sequencing This paper PRJNA595471
Experimental Models: Cell Lines
MIN6 Provided by Dr. C. Wolheim N/A
INS1E 832/13 with low passage number Provided by Boehringer Ingelheim GmbH N/A




KOMP repository Clone ID: 637131
Mouse. B6.RIP-Cre Provided by Prof. P. Herrera N/A
FLPe knock in/ROSA26 (FLP1 Deleter) The Jackson Lab Stock No:009086
Mouse Diabetic db/db B6.BKS(D)-Leprdb/J The Jackson Laboratory Stock No. 000697
Mouse.Akita mice: C57BL/6-Ins2Akita/J The Jackson Laboratory JAX: 003548
Oligonucleotides
siRNA: Human Jazf1 Dharmacon L-018012-01-0005
siRNA: Mouse Jazf1 Dharmacon L-055638-01-0005
siRNA: Rat Jazf1 Dharmacon L-108949-00-0005
siRNA: Srp54a Dharmacon L-099583-02-0005
siRNA: Dars Dharmacon L-096367-02-0005
siRNA: Gars Dharmacon L-095034-02-0005
siRNA: Rpl10 Dharmacon L-095634-02-0005
siRNA: Scramble Dharmacon D-001810-10
Sequence-Based Reagents
Primers for PCR, RT-qPCR and probes for
Northen blot analysis are listed in Table S4
This paper N/A
Recombinant DNA
Jazf1 adenovirus: Ad: Jazf1-HA-tagged This paper N/A
Gfp adenovirus: Ad:GFP This paper N/A
Nop56 (Myc-DDK-tagged) Origene MR209091
Tsr3 (Myc-DDK-tagged) Origene MR204683
Rps2 (Myc-DDK-tagged) Origene MR204027
Rps11 (Myc-DDK-tagged) Origene MR216516
Rps14 (Myc-DDK-tagged) Origene RC203889
Rps15 (Myc-DDK-tagged) Origene MR200959
Rps20 (Myc-DDK-tagged) Origene MR200561
Rpl10a (Myc-DDK-tagged) Origene MR200782
Rpl12 (Myc-DDK-tagged) Origene MR201323
Rpl13 (Myc-DDK-tagged) Origene MR202263
Rpl13a (Myc-DDK-tagged) Origene MR202103
(Continued on next page)






Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, MS
(stoffel@biol.ethz.ch).
Materials Availability
The Jazf1fl/fl mouse line (Jazf1tm1a (EUCOMM) Wtsi) is deposited at the European Conditional Mouse Mutagenesis Program
Eucomm.
Data and Code Availability
The accession numbers for the RNA-seq and ChIP-seq data reported in this paper are ArrayExpress: PRJNA595139 and ArrayEx-
press: PRJNA595471, respectively.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mouse models
All animals were housed in a pathogen-free animal facility at the Institute of Molecular Health Sciences at ETH Zurich. Mice were
maintained on a 12-h light/ dark cycle (lights on from 6:00 to 18:00). Mice were given ad libitum access to a standard laboratory
chow or HFD (SAFE, 260HF) containing 20% protein, 36% lipids and 36.7% carbohydrate, and water. Male mice were used for
all experiments shown (except Akita) and the age of mice was above 8-12 weeks unless otherwise indicated in Figures. All mice
were maintained on a pure C57BL/6N background. Genotypings of Jazf1fl/fl, Rip-Cre or Akita mice were performed by PCR with
primers listed in Table S4. All animal experiments were in accordance with institutional guidelines and approved by the kantonale
Veterinäramt Z€urich.
Generation of bJazf1KO mice
Mouse.C57BL/6.Jazf1:tm1a(EUCOMM)Wtsi
Mice carrying the Jazf1 mutation (Jazf1tm1a (EUCOMM) Wtsi) were obtained from the Knockout Mouse Project (KOMP) repository
(https://www.komp.org/ProductSheet.php?cloneID=637131). Briefly, Jazf1tm1a (EUCOMM)Wtsi mice contain an IRES:LacZ trap-
ping cassette and a floxed promoter-driven neo cassette inserted. Jazf1tm1a(EUCOMM)Wtsi mice were initially crossed with Flp-
1 trangenic line (Jackson Lab) to remove the FRT-flanked lacZ-neo cassette, converting the ‘‘knockout-first’’ allele to a conditional
allele (Jazf1fl/fl). To generate the beta cell-specific knockout animals (bJazf1KO), Jazf1 floxed mice were crossed with RIP-Cre trans-
genic mice leading to exon 3 deletion. RIP-Cre Jazf1 KO mice were maintained on a C57BL/6N background.
Rip-Cre mice (Tg(Ins2-cre)23Herr) were kindly provided by P. Herrera. A 0.6 kb fragment containing the rat insulin promoter was
adjoined to the Cre recombinase coding sequence to drive expression in pancreatic cells. The insertion of the transgene is
unknown.
Continued
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Software and Algorithms
Prism 8 GraphPad https://www.graphpad.com/
scientific-software/prism/
Progenesis QI for proteomics Nonlinear Dynamics http://www.nonlinear.com/progenesis/
qi-for-proteomics/
Fiji Fiji ImageJ https://fiji.sc/
Integrative Genomics Viewer (IGV) tool
version 2.4
Robinson et al., 2010 N/A
(Enrichr) Enrichment analysis Kuleshov et al., 2016 http://amp.pharm.mssm.edu/Enrichr/
MEME suite Machanick and Bailey 2011 N/A
NHR-scan Sandelin et al.,2004 N/A
FGCZ Heatmap Generated by SUSHI http://fgcz-shiny.uzh.ch/
fgcz_heatmap_app/
Other
Normal Chow Diet KLIBA NAFAG 3437
High Fat Diet SAFE 260HF






Male mice were fed a HFD starting at 5 weeks old for 12 weeks.
Blood glucose measurements IPGTT and BrdU injection
Mice were fasted for 6 h and injected intraperitoneally with D-glucose (Sigma, 49139) solution (2.5 g/kg dose for chow diet mice and
1.5 g/kg for HFDmice) for IPGTT experiment. Blood glucose values were measured with a Bayer Contour XT glucometer at 0, 15, 30,
45, 60, and 120 min after injection.
For b-cell proliferation study, mice were injected intraperitoneally with Brdu (100 mg/kg) (Sigma, B5002) for 2 days before mouse
dissection.
Cell culture and transfections
INS1E
Initial stocks of the clonal INS1E 832/13 were provided by Boehringer IngelheimGmbHwith passage number 85 (P85) and cultured in
RPMI 1640 supplemented with 11.1 mMD-glucose, 10% (v/v) fetal bovine serum (FBS), 10 mMHEPES, 1 mMPyruvate, 50 mMbeta-
mercaptoethanol, 2 mM Glutamax (GlutaMAX, Invitrogen) and 10,000 units/mL penicillin and 10 mg/mL streptomycin. Cells were
incubated at 37C in 5% CO2, 95% air. All experiments used cells harvested between passages P88-90.
MIN6
The initial stock of the clonal MIN6 cell line was obtained by Prof. C. Wolheim. Cells were cultured in DMEM supplemented with 20%
(v/v) FBS, 2 mM Glutamax (GlutaMAX, Invitrogen), 30 mM beta-mercaptoethanol and 10,000 units/mL penicillin and 10 mg/mL
streptomycin.
EndoC-bH2:
Cells were obtained from Univercell biosolutions company. Cells were culture in complete medium culture (Reference: OPTIb1 )
INS1E, MIN6 and EndoC-bH2 cell lines were authenticated in-lab by performing GSIS assays and by RT-PCR of beta-cell specific
genes. Cells are routinely tested twice annually for the presence of Mycoplasma and found negative.
INS1E, MIN6, EndoC-bH2 cells were maintained at 37 C in a humidified incubator with 5% CO2 in air.
Expression and purification of recombinant Zinc finger domains
To prepare pureGST proteins, BL21(DE3) cells were grown at 37 C in a fermentor to an A600 of0.5. Protein expression was induced
with isopropyl 1-thio-b-D-galactopyranoside (0.5 mM) and protein allowed to accumulate for an additional 4h. Following centrifuga-
tion, a pellet from 6 l of culture was resuspended in ZnF buffer (10 mM NaH2PO4, pH 7.4, 150 mM NaCl, 5 mM b-ME, 10 mM ZnCl2). All
purification steps were performed at 4C. Bacteria were lysed by sonication and the lysate was centrifuged (40,000 x g for 30 min) to
remove insoluble debris. GST-ZF23 and GST-JAZF1 was recovered from the lysate by affinity chromatography using a GSTPrep FF
16/10 affinity column (Amersham Biosciences). Bound protein was washed with 10 column volumes of ZnF buffer and eluted with
20mMglutathione in 50mMHEPES, pH 7.4, 5mM b-ME, and 10 mMZnCl2. Purification of MBP-fusion proteins were done in a similar
manner.
Antibody production
Protein fragments corresponding to amino acids 1-243 and 170-243 of JAZF1 fused to glutathione S-transferase (GST) were ex-
pressed, purified using glutathione Sepharose 4B (Amersham Biosciences) and used to raise JAZF1- N64 antibodies. JAZF1 anti-
bodies were raised in rabbits immunized seven timeswith 500 mg of theGST-fusion protein (Davids Biotechnoligie GmbH (Germany)).
JAZF1 specific antibodies were purified from 50 mL of serum in PBS on a Sepharose 2B column containing identical JAZF1 frag-
ments fused to maltose-binding protein (MBP) coupled to CNBr activate Sepharose 2B beads and eluted with 0.1 M glycine (pH 2.5).
Recombinant adenoviruses
Recombinant Adenovirus were generated by cloning the murine Jazf1 cDNA into pVQAd CMV K-NpA (pVQAd, Viraquest). Ad-Ctrl
was based on the same vector backbone (with a GFP) but lacked the Jazf1 transgene.
For virus infection experiments, cells were infected with Ad-Jazf1 or Ad-GFP at a MOI 5 for cells and a MOI 20 for dispersed islets.
Human islets and pancreatic sections
Human islets were obtained from Prodo Laboratories Inc. Pancreatic biopsy specimens from Caucasian patients were obtained
postmortem at the University Hospital, Zurich. Pancreatic specimens were formaldehyde fixed for histopathological examination.
Informed consent was obtained in accordance with the regulations of the Ethics Committee of the Canton Zurich.
Isolated Islets were from healthy and T2D donors (see table below). The islet preparation of donors consisted of 2,500 – 10,000 islet
equivalents with a purity of >80% and a viability of >90%. Pancreatic islets were handpicked under a microscope and cultured in
CMRL-1066 medium containing 5.6 mM glucose, 10% FBS, 100 IU/ml penicillin/streptomycin and glutamax.





Mouse pancreatic islets were isolated frommalemice as previously described (Zmuda et al., 2011) with slightmodifications. A total of
2 mL of Liberase (5 mg/ml) (Sigma 05401127001, diluted in HBSS buffer, GIBCO, 14170-112) was injected through the common bile
duct to perfuse the whole pancreas. The perfused pancreas was dissected and incubated at 37C for 17min. Digested exocrine cells
and intact islets were separated via centrifugation (24003 rpm for 20 min with very slow acceleration and no braking) over Histopa-
que-1077 (Sigma, 10771), and intact islets were manually picked under the microscope. Islets were cultured in RPMI 1640 with 10%
FBS and 100 U/ml penicillin/streptomycin.
METHOD DETAILS
Immunohistochemistry and b-cell mass measurements
Whole pancreas or pancreatic buds were fixed with 4% paraformaldehyde (PFA) and embedded in paraffin, and the cut sec-
tions were antigen-retrieved by boiling them in citrate buffer (10 mM Citric Acid, 0.05% Tween 20, pH 6.6). Cells or dispersed
islets were fixed with 2% PFA for 15 min. The sections or cells were permeabilized and blocked in PBS containing 0.1% Triton
X-100, 1% BSA and 5% goat serum. Primary antibody binding was performed overnight at 4C, while secondary antibody in-
cubation was carried out at room temperature (21C) for 1h. Leica TCS SP8 confocal microscope was used for fluorescent
imaging.
For b-cell mass, Ki-67 or BrdU labeling and Tunel assay, 3.5 mm sections were cut and 5 sections that were at least 500mm
apart were taken from each mouse and stained for insulin and DNA (Hoechst). Entire pancreatic sections were scanned using
Panoramic 250 Slide scanner (3D Histech). The fraction of insulin positive area compared to total pancreatic area (stained with
Hoechst) was analyzed using Fiji software (https://fiji.sc/), and b-cell mass was calculated by multiplying this fraction by the initial
pancreatic weight.
For nucleolar and nuclear area, MIN6 cells are transfected with Jazf1 or scramble siRNAs for 48h. Cells are fixed with 2% PFA for
15 min then are permeabilized and blocked in PBS containing 0.1% Triton X-100, 1% BSA and 5% goat serum. The nucleolus was
detected by Fibrillarin antibody, and the nucleus was detected by Hoechst staining and fluorescence images were observed using a
Zeiss Apotome 2 microscope. The area of the nucleolar and nuclear regions was quantified using Fiji software (https://fiji.sc/).
For cell proliferation assay, INS1E cells were transfected by a reverse transfection with Jazf1 or scramble siRNAs for 48 h. Cells
were fixed with 2% PFA for 15 min, then permeabilized and blocked in PBS containing 0.1% Triton X-100, 1% BSA and 5% goat
serum. The nucleus was detected by Hoechst staining and fluorescence images were observed using a Zeiss Apotome 2
microscope.
Insulin and Proinsulin
To determine mouse serum insulin or Proinsulin levels, blood was obtained from the tail vein and centrifuged for serum separation.
Insulin was measured by Insulin ELISA Kit (ALPCO, 80-INSRTU-E10-AL) and Proinsulin was measured by ELISA Kit (Mercodia, 10-
1232-01). To measure total pancreatic insulin content, insulin was extracted by acid-ethanol buffer (HCl:Ethanol 1:49, 0.1% Triton)
from total pancreas. For islet insulin content, insulin was extracted by acid-ethanol buffer (HCl:Ethanol 1:49, 0.1%Triton) from 80 size
matched islets. Hormones were then assessed by Insulin ELISA Kit.
Dispersed islets experiments
Islets were digested by 0.05% trypsin at 37C for 5 min, and then centrifuged and resuspended. Cells were seeded into a 96-well
plate which was coated overnight with medium from 804G cell line culture (Langhofer et al., 1993). Dispresed islets were cultured
in low or high glucose. Leica TCS SP8 confocal microscope was used for fluorescent imaging.
Donor Gender Age Diagnosis Cause of death BMI
1 M 29 N Stroke 42.2
2 M 45 T2D Stroke 27.3
3 M 60 N Stroke 27.4
4 F 53 N CVD 32
5 M 48 T2D Gunshot 43.7
6 M 43 T2D Stroke 27.6
7 M 59 T2D Stroke 32.5
8 M 37 N Stroke 25.4
9 M 57 N Stroke 29.4
10 F 41 T2D Stroke 43.1





For knockdown experiments cells, INS1E or MIN6 were plated in 6 well plates and transfected the next day at 60%–70% confluency.
For each well to be transfected, an RNAi duplex-Lipofectamine RNAiMAX complexes was prepared as follows: 30 nM (final con-
centration) RNAi duplex was diluted in Opti-MEM reduced Serum Medium. 7 ml of Lipofectamine RNAiMAX was diluted in Opti-
MEM, andmixed gently. The diluted RNAi duplex was combined the diluted LipofectamineRNAiMAX andmixed gently. The RNAi
duplex-Lipofectamine RNAiMAX complexes were incubated for 10 min at room temperature before transferring them to each well
containing cells. The medium was changed after 6 h and cells were incubated for 48 h at 37C in a CO2 incubator.
For transient plasmid transfections INS1E or MIN6 cells were plated in 6 well plates with growth medium without antibiotics over-
night and transfected the next day at 60%–80% confluency. Using a DNA (ug) to Lipofectamine 2000 (ul) ration of 1:3. The liquid was
gently mixed by rocking the plate back and forth and incubated at 37C in a CO2 incubator. The medium was changes after 6 h and
incubated for 42 h before harvesting the cells. Successful transfection and expression of vector in cells was assessed by RT-qPCR
and or western blotting.
Treatment with reagents
Cells or islets are treated with 5nM of Actinomycin D (Ribosome stress) or 500 nM thapsigargin (ER stress), cytokines cocktail (10 ng/
ml IL-1b, 100 ng/ml IFN-g and 25 ng/ml TNF-a), low glucose (3mM), high glucose (15mM) or chronic high glucose (25mM). The dura-
tion of treatments is indicated in the figure legends for each experiment.
Stress induction of human islets with glucose, palmitate, and cytokines
Islets were from donors. The islet preparation of donors consisted of 2,500 islet equivalents with a purity of >80% and a viability of
>90%. Pancreatic islets were handpicked under amicroscope and cultured in CMRL-1066medium containing 5.6mMglucose, 10%
FBS, 100 IU/ml penicillin/streptomycin and glutamax; then islets were challenged with 25 mM glucose, cytokines (10 ng/ml IL-1b,
100 ng/ml IFN-g and 25 ng/ml TNF-a) and 100 uM of palmitate-BSA conjugate. Medium was renewed every 24 h. Islets were
collected for experiments after 72 h.
RNA isolation and quantification
TRIzol reagent (Invitrogen, 15596-026) was used for RNA isolation according to the manufacturer’s protocol. RNA was reverse tran-
scribed using High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, 4368813). Quantitative PCR was performed in an
LC480 II Lightcycler (Roche) and using gene specific primers and Sybr Fast 2x Universal Master mix (Kapa biosystems, KK4611).
Results were normalized to 36b4 or GapdhmRNA levels. The sequences of primers pairs of respective transcripts are shown in Table
S4.
Northern blot
Total RNA from indicated cells or islets were extracted by TRIzol (Invitrogen). RNA samples (3-5mg) were heated in RNA loading buffer
contains 62.5%deionized formamide, 1.14M formaldehyde, 200 mg/ml bromphenol blue, 200 mg/ml xylene cyanole, inMOPS-EDTA-
sodium acetate at 1.25x working concentration (Sigma-Aldrich R1386) and were electrophoresed in 0.8% formaldehyde-agarose
gels (0.8 % agarose – 2.2 M formaldehyde gel) in 1XMOPS buffer at 45 V/cm and transferred onto Hybond N+ membranes (Amer-
sham) with 10 x SSC. ETS, ITS1 and ITS2 probes (sequences indicated in Table S4) used to generate a-32P dCTP-labeled probes.
Probeswere purified over nucleotide purification columns (ZymoResearch) prior to hybridization. Membraneswere prehybridized for
1 hr at 65C in 50% formamide, 5 3 SSPE, 5 3 Denhardt’s solution, 1% w/v SDS, 200 mg/ml salmon sperm DNA. The 32P-labeled
oligonucleotide probe was added and incubated overnight at 50C. Blots were developed on PhosphorImager screens and devel-
oped on a Typhoon Imager. Northern blot quantification based on densitometry of bands was performed in ImageJ.
Luciferase assay
Wild-type, mutant, and deletion of NR2C2 element in the promoters region of the human Ins, rat Rps14 and Rpl10 genes were gener-
ated by de novo DNA synthesis (Gene Universal) and cloned to a luciferase reporters (pGL4.25[luc2CP/minP] Vector (Promega cat#:
E8411).
INS1E or ENDOC-bH2 cells were grown in until cells were 60%–80% confluent. Cells were cultured in 96-well plates and trans-
fectedwith 30 nM si-RNA of si-Jazf1 or si-Scramble. After 24h, cells are transfected with 200 ng of a luciferase reporters vector under
the control of the wild-type and mutants promoters and with 100 ng of pRL Renilla luciferase control reporter vector (Promega cat#:
E2411) as an internal control for transfection efficiency. The complex of DNA/lipofectamine 2000 are used 1:3 ratio. One day after
transfection, cells were harvested and assayed using the Dual-Luciferase Reporter Assay System (Promega).
Polysome profiling
MIN6 cells were treated with 0.1 mg/mL cycloheximide (Sigma-Aldrich) for 5 min at 37 C, washed twice with 0.1 mg/mL cyclohex-
imide in 1X PBS. Polysome lysis buffer composed of 15mMTris HCl pH 7.4, 15mMMgCl2, 300mMNaCl, 100 mg/mL cycloheximide,
1% Triton X-100, 40 U/mL RNase and protease inhibitors. The lysis buffer was used to resuspend cells, followed by 10min incubation
on ice and 5min centrifugation at 13,000 rpm at 4 C. Clear supernatants (1,5mg of protein) from lysed cells were loaded into the 10 to




50% sucrose gradient. After centrifugation for 4h at 320000 rpm at 4C in a SW41 rotor (BeckmanCoulter), gradients were analyzed at
OD254 with a Foxy Jr. Gradient collector (Teledyne Isco).
Proteomic studies
107 INS1E cells were used per IP sample. Proteins were extracted by NP-40 buffer with protease inhibitors. Protein samples were
digested to peptides with Filter-aided Sample Preparation (FASP) method (Wisniewski et al., 2009). Peptide enrichment was per-
formed after FASP with Ti-IMAC (Resyn Biosciences, MR-TIM002). Enriched peptides were dissolved in 10 ml LC-MS solvent (3%
acetonitrile, 0.1% formic acid) after C18 ZipTip (Millipore, ZTC18S096) desalting.
Mass spectrometry analysis was performed on an Orbitrap Fusion Tribrid mass spectrometer (Thermo Scientific, San Jose, CA),
which was connected to an Easy-nLC 1000 HPLC system (Thermo Scientific). Liquid chromatography solvent compositions in chan-
nels A and B were 0.1% formic acid in water and 0.1% formic acid in acetonitrile, respectively. 4 ml of the sample in LC-MS solvent
was loaded onto a frit column (inner diameter 75 mm, length 15 cm) packed with reverse phasematerial (C18-AQ, particle size 1.9 mm,
pore size 120 Å, Dr. Maisch GmbH, Germany), and separated at a flow rate of 300 nL per min. The following LC gradient was applied:
0 min: 1% buffer B, 80 min: 30% B, 90 min: 50% B, 95 min: 98% B, 100 min: 98% B.
Survey scanswere recorded in theOrbitrapmass analyzer in the range ofm/z 350-1800, with a resolution of 60000, and AGC target
value of 200,000 and a maximum injection time of 50 ms. Higher energy collisional dissociation (HCD) spectra were acquired in the
linear ion trap analyzer, using a normalized collision energy of 30%. A maximum injection time of 100 ms, and an AGC target value of
30,000 were applied. The precursor ion isolation width was set to m/z 2,0. Charge state screening was enabled, and only precursor
ions with charge states 2-7 were included. The threshold for signal intensities was 5000, and precursor masses already selected for
MS/MS acquisition were excluded from further selection during 45 s.
Immunoblot analysis
Cells or islets were collected and lysed by RIPA Buffer (50 mM Tris pH 7.5, 1% NP-40, 0,5% Na-Deoxycholate, 0.1% SDS, 150 mM
NaCl, 1 mM EDTA pH 8.0, supplemented with protease and phosphatase inhibitors. Protein concentrations were determined by Bi-
cinchonic Acid (BCA) assay. 30-50 mg of total protein lysates were mixed with Laemmli buffer and boiled for 5 min. 10%–14% SDS-
PAGE gel was used for protein separation. Membranes were blocked by 5%milk/TBS-T or 5% BSA/TBS-T (for phosphorylation an-
tibodies) for 1 h after electrotransfer to nitrocellulose membranes (NBA083C001EA, Perkin Elmer) and incubated with appropriate
antibodies overnight at 4C. Membranes were exposed to secondary antibodies for 1 h at room temperature and developed using
ECL Western Blotting Substrate (Thermo, 32106). Immunoblotting quantification based on densitometry of bands was performed in
ImageJ
Cellular fractionation
Freshly isolated islets were digested with trypsin into single cells and washed with PBS. Cell pellet was re-suspended in Hypotonic
Lysis Buffer (HLB, 10mMHEPES, 1.5mMMgCl2, 10mMKCl, 1mMDTT and fresh protease inhibitor) and incubated on ice for 30min.
6 mL 10% NP40 per 100 mL HLB was added after the incubation and vortexed for 10 s, then centrifuged immediately for 30 s. Super-
natant was saved as cytosolic extract. The nuclei were then washed with 1 mL of HLB to remove any contaminating cytoplasm and
re-sedimented. Pellet was re-suspended in Nuclear Lysis Buffer (NLB, 10 Mm HEPES, 100 mM KCl, 3 mM MgCl2, 0.1 mM EDTA,
1 mM DTT and fresh protease inhibitor) and incubated on ice for 30 min. Extra 1/10th volume of 4 M (NH4)2SO4 was added over
30 min. Solution was centrifuged and the supernatant was saved as nuclear extract.
Protein concentrations were determined by bicinchoninic acid (BCA) assay and equal amounts of protein were loaded for
immunoblotting.
Co-Immunoprecipitation assay
107 INS1E cells are used per IP sample. Cells are whased twice in cold 1x PBS. Cells are lysed in NP-40 buffer (20 mM Tris HCl pH
8,137mMNaCl, 1%NP-40, 2mMEDTA) for 30min in ice. Cellular debris were removed by centrifugation at 4C for 10min and trans-
fer the supernatant to a new 2mL tube. Save 4%of the lysate as an input control, the remaining lysate were adjusted to the volume of
1.5 mL with pre-cold lysis buffer. Add 70 ul of anti HA magnetics beads against the HA tagged Jazf1 protein. Incubate the tubes on a
tube rotator 4h at 4C. (same for IgGmouse: negative control). Wash 5 times the beadswith the lysis buffer. After washing, resuspend
the beads in 30 mL of 2x Laemmli buffer, boil for 5 min, and analyze by immunoblot analysis.
Puromycin analysis
The cells or isolated pancreatic islets were treated with puromycin (1 mg/ml) for 30 min in fresh medium. The cells were lysed and
protein synthesis was detected with anti-puromycin antibodies by western blot.
Illumina RNA sequencing
Total RNAwas isolated from islets using PicoPureRNA Isolation Kit (Invitrogen, KIT0204). Sequencing libraries were prepared from
100-500 ng total RNA using the TruSeq RNA Sample Preparation Kit v2 (Illumina) according to the manufacturer’s protocol. Briefly,
total RNA samples (100–1,000 ng) were polyA selected and reverse transcribed into double-stranded cDNA. Then cDNA samples




were fragmented, end repaired, and polyadenylated before ligation of TruSeq adaptors containing the index for multiplexing frag-
ments on both ends were selectively enriched with PCR. The quality and quantity of the enriched libraries were validated using Qubit
(1.0) Fluorometer and the Caliper GX LabChip GX (Caliper Life Sciences). The product is a smear with an average fragment size of
approximately 260 bp. The libraries were normalized to 10 nM in Tris-Cl 10 mM, pH 8.5 with 0.1% Tween-20.
The quality of RNA-seq reads were checked with fastqc, which computes various quality metrics for the raw reads. Reads were
aligned to the genome and transcriptome with TopHat v. 1.3.3 (https://ccb.jhu.edu/software/tophat/manual.shtml). Before map-
ping, the low-quality ends of the reads were clipped (three bases from the read start and 10 bases from the read end). TopHat
was run with default options. The ‘fragment length’ parameter was set to 100 bases with a standard deviation of 100 bases.
On the basis of these alignments, the distribution of the reads across genomic features was assessed. Isoform expression was
quantified with the RSEM algorithm (Li and Dewey 2011) with the option for estimation of the read start position distribution turned
on. Transcripts were defined using the Ensemble annotations over protein-coding mRNAs. Differential expression analysis of map-
ped RNA-seq data were performed using EdgeR (Robinson et al., 2010).The raw sequencing data were deposited at NCBI
Sequence Read Archive (SRA, https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA595139) and are accessible through the
accession number PRJNA595139.
Jazf1 expression in islets from human and mouse T1D model
RNA-seq dataset from islets of human T1D (Mastracci et al.,2018: Accession number GSE102371). RNA-seq dataset from islets of
B10.RagKO and NOD.RagKO mice (Dooley et al., 2016: Accession number GSE56507). Array expression data from islets of NOD
mice. (Carrero et al., 2013: Accession number GSE41203).
The expression data of individual samples were merged, transcript expression was converted to gene expression and ensembl
gene idsweremapped to HGNC symbols. Differential gene expression analysis was carried out byDESeq2.The datawere processed
using in-house Python and R scripts. The Affymetrix MoGene IDs were annotated to ensembl IDs, gene symbols, chromosome loci
etc. by the Biomart R package.
ChIP-Seq assay
107 INS1E cells are used per IP. Cells were crosslinked with 1% formaldehyde for 10 min at room temperature, crosslinking was
stopped by addition of 2M Glycine (0.125M final concentration) at room temperature for 5 min. Cells are washed twice in cold 1x
PBS. Cells are lysed into ice-cold lysis buffer (50 mM Tris-HCl, pH 8.1, 1% SDS, 10 mM EDTA, 1X protease inhibitors) for 1h in
ice. Following cell lysis, the samples were sonicated (Bioruptor Plus, Diagenode) to generate fragments of average length of 300-
100 base pairs. Cellular debris were removed by centrifugation at 4C for 10 min (10,000 g), 10 % of the lysate was stored as the
source of ‘‘Input’’ and the remaining lysate was diluted 8 times in dilution buffer (final concentration: 16.7 mM Tris-HCl, pH 8.1,
0.01 SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM NaCl, protease inhibitor), in presence of 70 mL of anti-HA Magnetic beads
were then incubated at 4C with rotating for overnight.
Beads were washed extensively at 4C in Low salt buffer (20mM Tris-HCl, pH 8.1, 0.1% SDS, 1%Triton X-100, 2mM EDTA,
150 mM NaCl), in High salt buffer (20mM Tris-HCl, pH 8.1, 0.1% SDS, 1%Triton X-100, 2mM EDTA, 500mM NaCl), and in LiCl
buffer (10mM Tris-HCl, pH 8.1, 250mM LiCl, 1% NP-40, 1% sodium deoxycholate, 1mM EDTA), and finally in 1ml of TE buffer
(10mM Tris-HCl, pH 8.0, 1mM EDTA). The bound chromatin was released from the beads by vortexing at room temperature in
200 mL elution buffer (1% SDS and 100 mM NaHCO3). 1 mL of 10mg/ml RnaseA and 5M NaCl (200mM final concentration)
was added to the eluate and incubated O/N at 65C, and then treated with Proteinase K for 1 hr at 55C; DNA was purified using
QIAGEN PCR purification kit.
ChIP-seq data processing
Short reads generated in this study were deposited at NCBI Sequence Read Archive (SRA, https://www.ncbi.nlm.nih.gov/bioproject/
?term=PRJNA595471) and are accessible through the accession number
PRJNA595471. Adaptor sequences and low quality stretches within the reads were removed with TrimGalore (options –illumina,
version version 0.4.0, www.bioinformatics.babraham.ac.uk/projects/trim_galore). Reads were then aligned to the rat reference
genome (ensembl93) with bowtie2 keeping only unique alignments with a mapping quality greater than 10 (version 2.8.2, Langmead
and Salzberg, 2012). For each sample, coverage peaks were identified with MACS (version 2.1.1; Zhang et al., 2008) with a Q-value
threshold of 0.05 for the identification of broad peaks. Peaks of the two batch 1 and the four batch 2 replicates were merged with
MULTOVL and only peaks identified in at least two batch 1 or at least three batch 2 replicates were kept (version 1.3, options -m
3 -u; Aszódi,2012). Reads overlapping with at least 30 bases with the peaks were counted with featureCounts (version 1.6.0, multiple
overlaps allowed, Liao, Smyth, and Shi,2014). Peaks not mapped by at least five reads in any of the samples were excluded from
further analyses. Peak regions were mapped to the genomic context (e.g., promoter or intergenic) with Homer (version 4.10, Heinz
et al., 2010) and the rn6 annotation.
Differential binding
Variation in sequence counts between IP and control conditions was analyzed with a general linear model in R with the package DE-
Seq2 (version 1.14.1, (Love, Huber, and Anders, 2014)). We first fitted a factor to account for batch effects (batch + treatment). p




values were adjusted for multiple testing (Benjamini-Hochberg), and peaks with an adjusted p value (false discovery rate, FDR) below
0.05 and a minimal log2 fold-change (i.e., the difference between the log2 transformed, normalized sequence counts) of 0 were
considered to be significantly bound by Jaz1. Normalized sequence counts were calculated accordingly with DESeq2 and
log2(x+1) transformed.
Functional characterization with GO terms
To functionally characterize genes with a significantly Jaz1-bound peak in their promoter (1 kb up- and downstream of the transcrip-
tional start site), we tested for enrichment of gene ontology (GO) terms with topGO (version 2.28 Alexa, Rahnenf€uhrer, and Lengauer,
2006) in conjunction with the GO annotation from Ensembl available through biomaRt (Durinck et al., 2009). Analysis was based on
gene counts using the ‘‘weight’’ algorithm with Fisher’s exact test (both implemented in topGO). A termwas identified as significant if
the p value was below 0.05.
Enrichment of KEGG pathways in gene sets was tested with clusterProfiler (version 3.12.0, Yu et al., (2012)) using the gene to
pathway mappings available through biomaRt (Durinck et al., 2009) and the package org.Rn.eg.db (version 3.8.2, Carlson,
2019).
Motif discovery
To search for known and novel motifs we used MEME-ChIP and 2 kb sequences centered around significantly Jaz1-bound peaks
(version 5.0.2 with the parameters -meme-mod zoops -meme-minw 6 -meme-maxw 30 -meme-nmotifs 10 -dreme-e 0.05 -cen-
trimo-score 5.0 -centrimo-ethresh 10.0, Machanick and Bailey (2011)). The percentage of peaks with a motif similar to CCGGAA
was extracted from the CentriMo output (part of the MEME-ChIP pipeline). To further search for the presence of nuclear hormone
receptor binding sites in significantly Jaz1-bound peaks in promoter (1 kb up- and downstream of the transcriptional start site)
and intergenic regions we used NHRscan with default settings (available at nhrscan.genereg.net, accessed at the 24th of November
2019, Sandelin and Wasserman, 2005).
UK BioBank data processing
The genotype data from rs1635852 (affy30273931) was obtained through UK Biobank application number 48008. The data were ex-
tracted and filtered for missing data using in-house scripts implemented with python 3.6 (python.org) and pandas (https://pandas.
pydata.org/). The cleaned initial dataset included 241196 participants with the C T genotype, 125147 participants with the T T geno-
type, 121524 participants with the C C genotype. The diabetic participants were 26740 (5.481% of the whole dataset). We applied
general linear model (GLM) to identify the association between the SNPs and phenotypes. In case of continuous phenotypes, GLM
with Gaussian link function was used. To analyze binary phenotypes like diabetes, we append GLMwith logit link function of binomial
distribution. The p values and effect sizes (beta coefficient in case of linear regression and odds ratio in case of logistic regression)
were used to assess the magnitude of the SNP effect on a given phenotype.
The Linear Regression used here can be written in the following form:
Y = b0 + snpb1 + ageb2 + sexb3 +pc1b4 +.+pc10b13 + ε
The Logistic Regression we applied may be written in the following form:
Y = 1=ð1 + expðb0 + snpb1 + ageb2 + sexb3 + pc1b4 + . + pc10b13 + eÞÞ
Generalized linear regression analysis was conducted on blood biochemical data (fields: 30630-0.0 Apolipoprotein A, 30640-0.0
Apolipoprotein B, 30690-0.0 Cholesterol, 30740-0.0 Glucose, 30760-0.0 HDL cholesterol, 30750-0.0 Glycated haemoglobin
(HbA1c), 30780-0.0 LDL direct, 30870-0.0 Triglycerides), biometric measurements (fields: 21001-0.0 BMI, 23106-0.0 Impedance
of whole body) using rs1635852 (affy30273931), age, sex, and genetic Principal Component 1-10 (field 31-0.0 sex, field 21022-
0.0 age at recruitment, field 22008-0.0 through 22008-0.10 for genetic principal components) as covariates. The reference genotype
used for analysis was C C. The blood biochemical data were available for 467,929 participants, while BMI and impedance for 485887
and 478818 participants, respectively. The additional covariates were included to account for the unwanted source of variation within
the population age, sex, ethnic diversity etc.
Logistic regression analysis was conducted on diabetes diagnosed by a doctor (field 2443-0.0, for 487,867 participants) and
medication use (Treatment/medication code fields 20003-0.0 through 20003-0.47, for 354,259 participants) using rs1635852
(affy30273931), age, sex, and genetic Principal Component 1-10 (field 31-0.0 sex, field 21022-0.0 age at recruitment, field
22008-0.0 through 22008-0.10 for genetic principal components) as covariates. The reference genotype used for analysis was
CC. Medications were grouped according to ATC pharmacological subgroups within therapeutic subgroup A10 (Wu et al.,
2019). Medications with different UK Biobank code but identical ATC subcode were grouped in the same category (A10A Insulin,
A10BA metformin, A10BB sulfonylurea, A10BG rosiglitazone, A10BD Metformin |Rosiglitazone, A10BF Acarbose, A10BX Megli-
tinide). The all_diabetes_medication data were obtained by calculating if a participant takes any diabetes medication, regardless
of the quantity.
R programming language (https://www.r-project.org/) with tidyverse library (https://www.tidyverse.org/) were used to conduct the
statistical analysis.




QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis
Statistical parameters including the exact value of n, precision measures (mean ± SD) and statistical significance are reported in the
Figures and Figure Legends. Two-tailed unpaired Student’s t test was applied for comparisons between two groups. ANOVA was
used on comparisons that involved multiple groups. Statistical differences are indicated as (*: p < 0.05; **: p < 0.01; ***: p < 0.001;
****: p < 0.0001). p < 0.05 was considered significant. Samples were not systematically blinded before every experiment. Biological
or technical replicates are indicated in the figure legends. Statistical analyses were performed using GraphPad Prism 8 software.
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